Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 17/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 15/20 | 0.60 |
| ▸ | RAB9A | P51151 | 13/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 10/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.60 |
| ▸ | MITF | O75030 | 7/20 | 0.60 |
| ▸ | POLB | P06746 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 2/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 11/20 | 0.55 |
| ▸ | LMNA | P02545 | 8/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 9/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18980129 | 0.87 | RAB9A (0.69) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL19000726 | 0.80 | NPSR1 (0.61) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL19011573 | 0.80 | RAB9A (0.60) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL19000703 | 0.80 | NPBWR1 (0.64) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL19000706 | 0.78 | HTT (0.77) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL1691901 | 0.78 | HTT (0.71) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL15674013 | 0.76 | HTT (0.59) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL10642561 | 0.75 | RAB9A (1.00) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL9123380 | 0.75 | HTT (0.72) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL18980224 | 0.73 | HTT (0.56) | HTTALDH1A1RAB9ANPSR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170173008-A1 | ANTIMICROBIAL AGENTS AND SCREENING METHODS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-06-22 | — | — | US | disclosed |
| US-20170173008-A1 | ANTIMICROBIAL AGENTS AND SCREENING METHODS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170173008-A1 | ANTIMICROBIAL AGENTS AND SCREENING METHODS | BAK1, DCLRE1B, BLVRB | HTT 4458/4885ALDH1A1 4273/4885RAB9A 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.